Notch-1 and Notch-4 Receptors as Prognostic Markers in Breast Cancer

Abstract

Background: Studies looking at immunohistochemical (IHC) staining of Notch receptors in breast cancer and correlation with known prognostic factors are sparse. Methods: IHC staining for nuclear, cytoplasmic, and membrane Notch-1 (N1), Notch-4 (N4), and Jagged-1 (JAG1) was performed and correlated with known prognostic factors. Results: Of 48 breast cancers, 36 (67%) were invasive, mean age was 50 years (range 43-86 years), 37 (77%) were estrogen receptor (ERα) positive, and 13 (27%) node positive. There was significantly more marked N1 membranous staining in ERα-positive tumors (P < .05). On univariate analysis, cytoplasmic N1 was significantly correlated with node status and tumor grade (P < .05); both cytoplasmic and membranous N4 significantly correlated with Ki67 (P < .05); and membranous JAG1 significantly correlated with Ki67 (P < .05). On multivariate analysis, only cytoplasmic N1 significantly correlated with node status. Conclusion: IHC of Notch markers is feasible and correlates with known prognostic factors consistent with a biological role of Notch signaling in breast cancer progression.

Keywords

breast cancer Notch receptors breast prognostic markers JAG1 Notch ligand Notch-1 Notch-4

Get full access to this article

View all access options for this article.

References

Miele

. Notch signaling. Clin Cancer Res. 2006;12:1074-1079.

Farnie

Clarke

Spence

. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst. 2007;99:616-627.

Baldi

DeFalco

DeLuca

. Characterization of tissue specific expression of N1 in human tissues. Biol Cell. 2004;96:303-311.

Callahan

Egan

. Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia. 2004;9:145-163.

Dievart

Beaulieu

Jolicoeur

. Involvement of N1 in the development of mouse mammary tumors. Oncogene. 1999;18:5973-5981.

Kiaris

Politi

Grimm

. Modulation of notch signaling elicits signature tumors and inhibits induced oncogenesis in the mouse mammary epithelium. Am J Pathol. 2004;165:695-705.

Gallahan

Callahan

. Mammary tumorigenesis in fetal mice: identification of a new int locus in mouse mammary tumor virus (Czech-II)-induced mammary tumors. J Virol. 1987;61:66-74.

Stylianou

Clarke

Brennan

. Aberrant activation of Notch signaling in human breast cancer. Cancer Res. 2006; 66:1517-1525.

Imatani

Callahan

. Identification of a novel N4/INT-3 RNA species encoding an activated gene product in certain human tumor cell lines. Oncogene. 2000;19:223-231.

10.

Weijzen

Rizzo

Braid

. Activation of Notch signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med. 2002;8:979-986.

11.

Soares

Balogh

Guo

Gartner

Russo

Schmitt

. Evidence for the Notch signaling pathway on the role of estrogn in angiogenesis. Mol Endocrinol. 2004;18:2333-2343.

12.

Reedijk

Odorcic

Chang

. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005;65:8530-8537.

13.

Dickson

Mulligan

Zhang

. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod Pathol. 2007;20:685-693.

14.

Rizzo

Miao

D’Souza

. Cross talk between Notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008;68:5226-5235.

15.

Miele

Golde

Osborne

. Notch signaling in cancer. Curr Mol Med. 2006;6:905-918.

16.

Schroeter

Kisslinger

Kopan

. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 1998;393:382-386.

17.

Le Borgne

. Regulation of notch signaling by endocytosis and endosomal sorting. Curr Opin Cell Biol. 2006;18: 213-222.